Rising Cost of Capital a Challenge for Early-Stage Biotechs
August 22, 2022
Raja, Kumaraguru
Some Hard-Hit Biotechs Trading at or Below Cash
March 18, 2022
Raja, Kumaraguru
COVID Vaccines in Pipeline Promise Effective Protection Against Variants
March 18, 2021
Raja, Kumaraguru
Cyclacel Pharmaceuticals, Inc. (CYCC)
September 07, 2012
Richard B. Hollis - Hollis-eden Pharmaceuticals, Inc. (heph)
September 24, 2007
Philip C.s. Yin & Wilson W. Cheung - Axt, Inc. (axti)
April 23, 2007
COMMUNICATIONS EQUIPMENT: RICHARD CHURCH - C.E. UNTERBERG, TOWBIN
July 11, 2006
